Innovation Spotlight Sponsors
|
Founded 2002 in Stockholm, Sweden, Attana's mission is to bridge the gap between biochemistry and cell-based assays by offering improved selection of drug candidates based on more biological relevant information.
With a strong focus on characterizing molecular interactions exactly as they occur in the human body, Attana is committed to offer tools and services with the goal of enhancing success rates and efficiencies in the complex process of developing pharmaceuticals. Attana’s biosensors are today used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria. |
|
Pall ForteBio products enable scientists in life science, pharmaceutical, and bioprocess research and development to perform quick and easy characterization of proteins and streamline the measurement of biomolecular interactions — while steering clear of the typical throughput and cost limitations associated with other methodologies.
|
|
Sai Life Sciences is a CRO/CMO providing integrated or standalone drug discovery, CMC development, cGMP commercial scale manufacturing services to startup, biotech & pharma companies since 1999.
Our Discovery services are diverse and support our customers in:
|
Platinum & Branding Sponsors
Inoviem Scientific is an innovation and technology driven Contract Research Biotech (CRB) that aims to support pharmaceutical and biotechnological companies in developing safer pharmacological agents. The company has developed two proprietary technologies which are complementary throughout the drug development process. Inoviem Scientific is comitted to human and financial investments in the development of complementary technologies to provide clients with creative and innovative technology solutions. Inoviem Scientific: Creative technologies for efficient therapeutics.
|
MercachemSyncom has a 30 year track record in assisting leading pharma and biotechnology companies with medicinal chemistry programs. Starting as a chemistry service provider, MercachemSyncom has transformed into an integrated drug discovery CRO offering chemistry services, in vitro screening, ADME studies, pharmacokinetics and in vivo pharmacology. Primary chemistry activities include medicinal chemistry services, synthesis of key building blocks, library synthesis, route scouting services, process research activities, scale up, cGMP manufacturing and hit-to-lead optimization programs.
|
Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with tailor-made services to drug discovery in the area of ADME-Tox. The service offering is widely spread over the whole ADME-Tox area, from highly tailored and optimised studies to High Throughput Screening (HTS). Admescope’s unique top-notch expertise lies in in vitro & in vivo drug metabolism; including metabolite profiling & identification, drug-drug interactions and quantitative bioanalysis. The right study assay can always be found whether in the discovery or lead optimisation phase.
|
Vivenics is an informatics company at the Pivot Park (Life Sciences Community) in Oss that delivers high value informatics consultancy and SaaS solutions to Life Sciences Research & Development organizations. Vivenics partners with leading service providers to enable delivery of a full service portfolio. Customers of Vivenics are determined to get better results from their data and work in the knowledge driven environment of Life Sciences Research organizations.
|
Cellular Technology Limited, (CTL) specializes in immune monitoring. Contract Laboratory Services: ELISPOT assays, high-throughput, multiplex Cytokine Bead Arrays (CBA), Flow Cytometry (phenotyping, multimer readouts etc.), Killer assays and BrdU proliferation assays. CTL is developing, qualifying/validating assays tailored to our clients’ needs in our GLP/GCP-compliant, CLIA-certified laboratory.
|
Bronze Partners & Exhibitors
Orbit Discovery - Peptides offer the potential to make drugs with the specificity and efficacy of large biologic molecules combined with the smaller dose size, simpler routes of delivery and lower cost of manufacturing found with small molecules. They are, therefore, uniquely suited to the treatment of chronic diseases which impact large patient populations. Our technology supports all of the improvements that can be made to peptides which make them better drugs whilst simplifying the discovery process and accelerating drug development.
|
Zymo Research, also known as "The Epigenetics Company", has been serving the academic and biopharmaceutical scientific communities by providing DNA and RNA purification products since its inception in 1994. It was an early adopter in the epigenetics field and offers a line of products used in DNA methylation detection and quantitation. In addition to the epigenetic and nucleic acid purification products, Zymo also provides the first commercially available microbiomics standards for the development, evaluation, calibration, and validation of complex microbiomics workflows.
|
Enamine is a chemical company producing building blocks and screening libraries of world reputation. The major asset of the company is the world’s largest collection of building blocks: 150,000 in stock with 2,000 additions synthesized each month. These research functionalized compounds provide a significant competitive advantage to the company in supplying custom compound libraries particularly in the frame of medicinal chemistry collaborations and compound collection enhancement programs.
|
KINSY is an independent chemical company, located in Murcia (Spain), having broad expertise in development, scale-up and commercial production of fine chemicals, with a strong focus on development and manufacturing of key pharmaceutical intermediates and APIs under cGMP.
|
Recipharm AB is a leading contract development and manufacturing organization (CDMO) based in Sweden. Operating from a few dedicated development centers Recipharm is able to develop candidate material all the way from medicinal and analytical chemistry research.
|
Selvita is one of the largest drug discovery companies in Europe. The company has two primary focus areas: to serve the drug discovery market as a customer centric provider of high quality, integrated drug discovery services, and as a drug discovery company engaged in the research and development of breakthrough therapies in oncology.
|
Private equity-backed Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery resource and expertise. Founded in 2004, the company undertakes complete drug discovery programmes for pharmaceutical and biotech clients, which include target validation, hit identification, hit-to- lead and lead optimisation phases. We have an enviable track record of success.
|
Over the years it has built up a partnership with a wide variety of specialist. From development of analytical methods, testing for “leachables” to Clinical Trial analysis under cGLP. Custom Synthesis of Intermediates, RSM and API's: We have a wide range of specialist in different branches of chemistry both in terms of size - a few grams to 10s of tons and chemistry including Aziridine, Carbohydrate, Continuous, Cryogenic, Cytotoxic, Hazardous Peptide, Piperdone / Piperidine, Plant extraction and Steroidal chemistry.
|
Cellectricon is an emerging chronic pain and CNS drug discovery partnership company that identifies and delivers novel drug candidates through phenotypic screening employing innovative in-vitro assays with enhanced translational power. Combining primary and stem cell-derived neuronal cell cultures with powerful genome editing technologies, we create highly relevant, complex disease models and assays for functional and morphological screening targeting a multitude of therapeutic indications where neuronal function is affected.
|
Evotec is a drug-discovery & development solutions company offering the life sciences industry a variety of ways to access drug discovery innovation & development expertise in a time efficient manner, as stand-alone or integrated projects and have the confidence that through creative deal making and high quality alliance and project management, their programmes are in safe hands.
|
Dotmatics delivers a ready-to-use platform to capture, register, share, collaborate, query, visualise and analyse all the information and knowledge generated in the modern, highly collaborative scientific industries. Dotmatics has significant expertise in scientific informatics, including database management for chemistry and biologics, electronic laboratory notebooks, chemical and biological registration, screening data management, SAR analysis, reporting, and visualisation.
|
PharmaCytics is a pharmaceutical Research company located in the Netherlands and offers a drug delivery solution, based on an advanced prodrug approach. The technology exploits intestinal transporter proteins as carriers for drug conjugates in which a transporter substrate is linked to a drug moiety. The drug conjugates are transported by specific nutrient transporter proteins that are abundantly present in the gut membrane.
|
Alderley Analytical is an independent UK-based bioanalytical service provider supporting clients bioanalytical needs in discovery, through pre-clinical development and into clinical development. We are a GLP and GCP compliant facility and have the capability to perform both regulated and non-regulated bioanalysis. The lab is equipped with state of the art Mass Spectrometers, including the Waters Xevo TQ-S, Sciex 6500+ and the Thermo Q-exactive Focus HRMS/MS detectors all coupled to UPLC Chromatographic systems. We also have ELISA and HPLC-UV capability.
|
Pivot Park Screening Centre (PPSC) provides drug discovery services in the field of assay development, lab automation, (ultra) High Throughput Screening ((u)HTS) and hit-2-lead testing to find novel leads for drug development. PPSC is an independent CRO, located on Pivot Park, an inspiring life sciences campus with focus on pharmaceutical R&D. Established in 2012 as a spin-off from Organon/MSD, PPSC uses a new, open innovation approach to build on the long-established history of screening in Oss, the Netherlands.
|
Discovery from Charles River is industry-proven in the successful development of novel therapies, with over 320 patents and 74 preclinical drug candidates delivered to our sponsors in the past 17 years. Backed by more than 650 scientists, our comprehensive, integrated portfolio employs the latest technology and platforms to provide chemistry, biology, and pharmacology services that support clients from the earliest stages of hit identification all the way through to IND.
|
Beckman Coulter Life Sciences is dedicated to developing and providing advanced technologies and equipment for research and discovery to explore new treatment methods. Our products include Particle Counting and Characterization, Centrifugation, Flow Cytometry, Liquid Handling and Genomic solutions which are implemented in all major areas of Life Sciences such as biology, biochemistry, biophysics, nanotechnology and molecular biology to simplify and automate existing processes in the lab. Our vision: Advancing science through discovery – Our mission: Delivering innovative and trusted scientific solutions across the globe.
|
ZeClinics is a Biotech Contract Research Organization (CRO) and early-phase biopharmaceutical (PHARMA) company using zebrafish for: 1) performing target validation, 2) developing disease models for several indications and 3) addressing the safety and efficacy of novel chemical molecules. ZeClinics’ business strength relies on high scientific expertise and top-notch research facilities, combined with strategic industrial partnerships and academic collaborations. The aim of the company is to challenge the traditional drug discovery pipeline by offering an economic, fast and robust array of customized assays, designed to address the safety and biomedical relevance of novel molecules.
|
In 2017, Magle AB – a medtech research and development company based in Skåne, in southern Sweden- merged with Chemoswed AB, an active pharmaceutical ingredients manufacturer with roots in Pharmacia and DuPont. Both companies brought with them extensive experience and longstanding operations – in Chemosweds case leading all the way back to 1944 – into the merger. Magle Chemoswed can now boast with knowledge and experience across the whole value chain, in pharmaceuticals and medical devices, from idea to product, and with a strong sense of unity and belief in the future. We combine our unique knowledge of formulating delivery systems and our drug development expertise to bring innovations from idea to product.
|
SOLVO Biotechnology, a member of Citoxlab Group, with its 19 years' experience is the leading and most experienced provider of in vitro membrane transporter assay services and products with a wide range of efflux and uptake transporter assays using stably transfected cells, membrane vesicles or primary cells according to the most up-to-date regulatory requirements. Beside individual transporter assays, SOLVO also provides different comprehensive barrier models for transporter mediated clearance, metabolism and toxicity assessments as well.
|
Labcyte, a global biotechnology tools company headquartered in San Jose, California, is revolutionizing liquid handling. Echo® liquid handling systems use sound to precisely transfer liquids without contact, eliminating the use of pipettes. Labcyte instruments are used worldwide throughout the pharmaceutical and biotechnology industries, as well as by hospitals, service laboratories, contract research organizations, and academic institutions.
|
Peak Proteins provide tailor-made protein reagents and generate protein structure information using X-ray crystallography. Proteins are notoriously individual and complex reagents that require careful thought and handling, from design through to purification, to produce high quality, active protein reagents. All our staff have years of drug discovery experience through working in large pharma organisations and have the in-depth scientific knowledge needed to produce protein reagents in a suitable format for assay development, high throughput screening, biophysics or structure determination.
|
